GLA
TNGX icon

Great Lakes Advisors’s Tango Therapeutics TNGX Stock Holding History

Great Lakes Advisors’s Portfolio TNGX Stock Details TNGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-294,303
Closed -$2.61M – 856
2025
Q4 		$2.61M Sell
294,303
-129,548
-31% -$1.12M 0.02% 374
2025
Q3 		$3.56M Buy
+423,851
New +$2.87M 0.03% 315

Other funds holding TNGX

RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
BCM
Boxer Capital Management San Diego, California $1.33B AUM 864.5% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return
TGI
TRV GP IV Boston, Massachusetts $254M AUM 426.76% 1-Year Est. Return

Great Lakes Advisors's TNGX Position: Q1 2026 in Review

Great Lakes Advisors sold out of Tango Therapeutics (TNGX) in Q1 2026, closing a stake of 294,303 shares — an estimated $2.61M sold.

Great Lakes Advisors first reported a position in TNGX in Q3 2025 and held it in 2 quarters. The position peaked at $3.56M in Q3 2025. 194 funds tracked by Wall St. Rank hold TNGX as of Q1 2026.

  • Great Lakes Advisors reported no remaining Tango Therapeutics position as of Q1 2026 after selling out during the quarter.
  • Great Lakes Advisors sold 294,303 Tango Therapeutics shares in Q1 2026, an estimated $2.61M.
  • Great Lakes Advisors first reported a position in Tango Therapeutics in Q3 2025 and held it in 2 quarters.
  • Great Lakes Advisors's Tango Therapeutics position peaked at $3.56M in Q3 2025.
  • 194 funds tracked by Wall St. Rank held Tango Therapeutics as of Q1 2026.

Based on Great Lakes Advisors's 13F filing for Q1 2026, filed 12 May 2026.